Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Extension of Protocol 002, Carbidopa-levodopa in Neovascular Extension of Protocol 002, Carbidopa-levodopa in Neovascular AMD

NCT03197493 is registered in ClinicalTrials.gov with Snyder, Robert W., M.D., Ph.D., P.C. as lead sponsor.

NCT NCT03197493
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03197493 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Extension of Protocol 002, Carbidopa-levodopa in Neovascular Extension of Protocol 002, Carbidopa-levodopa in Neovascular AMD
Lead sponsor
Snyder, Robert W., M.D., Ph.D., P.C.
Phase
Phase 2
Overall status
Completed
Start date
August 1, 2017
Completion date
July 9, 2020
Enrollment
35 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

macula; degeneration, retina